<DOC>
	<DOC>NCT02719522</DOC>
	<brief_summary>This is a prospective, single-arm, multi-center post-market observational study assessing the performance of the Pipeline™ Flex Embolization Device with Shield Technology™ in subjects undergoing treatment for intracranial aneurysms in a large real-world, post-market setting.</brief_summary>
	<brief_title>Pipeline Flex With SHield Technology Embolization - An International MulticEnter ObservationaL Post Market StuDy</brief_title>
	<detailed_description>Eligible subjects will be treated with the Pipeline™ Flex Embolization Device with Shield Technology™. Subjects will undergo standard of care follow-up visits. Data generated per standard of care will be collected for 1 year beyond the index procedure.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Subject has provided written Data Release Form (DRF) or informed consent using the Institutional Review Board (IRB)/ Ethic Committee (EC)approved consent form and agrees to comply with protocol requirements. At least 18 years of age. Subject has already been selected for flow diversion therapy as the appropriate treatment. Major surgery including endovascular procedures within the past 30 days. Subject with anatomy not appropriate for endovascular treatment. Stent is in place in the parent artery at the target IA location. Any known contraindication to treatment with the Pipeline™ Flex Embolization Device with Shield Technology™ per Instructions for Use. The investigator determines that the health of the subject or the validity of the study outcomes (e.g., high risk of neurologic events, conditions that may increase the chance of stroke, worsening of clinical condition in the last 30 days) may be compromised by the subject's enrollment. Pregnant or breastfeeding women or women who wish to become pregnant during the length of study participation. Subject is currently enrolled or planning to participate in a potentially confounding drug or device trial during the course of this study. Legal incapacity or evidence that a subject cannot understand the purpose and risks of the study or inability to comply fully with study procedures.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>